US Patent and Trademark Office has allowed claims covering the approved administration of BioMarin’s Kuvan (sapropterin dihydrochloride) with food, based on the discovery that food increases the bioavailability
Astellas and Theravance have announced that Health Canada has approved VIBATIV (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by
HRA Pharma has announced that ellaOne (ulipristal acetate, 30mg), its new generation emergency contraceptive, has been launched in France, Germany and the UK via local HRA teams. HRA
Provectus has initiated a phase 1 study of PV-10 for liver cancer. The study will enroll up to six subjects with cancer metastatic to the liver or with
Revenues for the fourth fiscal quarter ending June 30, 2009 were $10.5 million compared to $10.6 million for the three months ended June 30, 2008. The results reflect
Mylan has announced that its subsidiary Mylan Pharmaceuticals has received approval from the FDA for its Abbreviated New Drug Application (ANDA) for Carbidopa and Levodopa tablets USP, 10mg/100mg,
Aphios has been awarded a RC-1 Challenge grant (No 1RC1HL102822-01) from the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health’s (NIH) American Recovery and Reinvestment
Cord Blood America is opening its new corporate headquarters and cryogenic research and storage laboratory in Las Vegas, as planned, the first week of October. The facility will
Sosei has announced the submission of the New Drug Application (NDA) for the emergency contraceptive pill SOH-075 (NorLevo) to Ministry of Health, Labour and Welfare (MHLW) by Sosei
Pfizer has announced that the Australian Competition and Consumer Commission (ACCC) has approved the company’s pending acquisition of Wyeth. The ACCC’s decision includes Pfizer’s commitment to divest certain
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.